Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Other

Recommendations for collection and handling of specimens from group breast cancer clinical trials.

Go back to Resources

Recommendations for collection and handling of specimens from group breast cancer clinical trials.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Results of the cord blood transplantation (COBLT) study unrelated donor banking program.

Go back to Resources

Results of the cord blood transplantation (COBLT) study unrelated donor banking program.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Projected neurodegenerative disease mortality among minorities in the United States, 1990-2040.

Go back to Resources

Projected neurodegenerative disease mortality among minorities in the United States, 1990-2040.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Clinical trials referral resource. Current clinical trials in prostate cancer.

Go back to Resources

Clinical trials referral resource. Current clinical trials in prostate cancer.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin.

Go back to Resources

Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Clinical trials of single-agent oxaliplatin.

Go back to Resources

Clinical trials referral resource. Clinical trials of single-agent oxaliplatin.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Clinical trials with gadolinium-texaphyrin and lutetium-texaphyrin.

Go back to Resources

Clinical trials referral resource. Clinical trials with gadolinium-texaphyrin and lutetium-texaphyrin.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Current clinical trials of 17-AG and 17-DMAG.

Go back to Resources

Clinical trials referral resource. Current clinical trials of 17-AG and 17-DMAG.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Current clinical trials in CNS tumors.

Go back to Resources

Clinical trials referral resource. Current clinical trials in CNS tumors.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Multicenter trials of therapies for adult brain tumors.

Go back to Resources

Clinical trials referral resource. Multicenter trials of therapies for adult brain tumors.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Pagination

  • Previous page ‹‹
  • Page 40
  • Next page ››
Subscribe to Other
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification